这是一篇来自已证抗体库的有关人类 Toll样受体4 (TLR4) 的综述,是根据85篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Toll样受体4 抗体。
Toll样受体4 同义词: ARMD10; CD284; TLR-4; TOLL; toll-like receptor 4; hToll; homolog of Drosophila toll

艾博抗(上海)贸易有限公司
小鼠 单克隆(76B357.1)
  • 免疫组化; 大鼠; 图 6a
  • 免疫印迹; 大鼠; 图 6g
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化在大鼠样品上 (图 6a) 和 被用于免疫印迹在大鼠样品上 (图 6g). Brain Behav Immun (2017) ncbi
小鼠 单克隆(HTA125)
  • 免疫细胞化学; 小鼠; 1:200; 图 7d
  • 免疫印迹; 小鼠; 图 7a
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab 8376)被用于被用于免疫细胞化学在小鼠样品上浓度为1:200 (图 7d) 和 被用于免疫印迹在小鼠样品上 (图 7a). Sci Rep (2017) ncbi
小鼠 单克隆(76B357.1)
  • 免疫组化-冰冻切片; 大鼠; 1:100; 图 5a
  • 免疫印迹; 大鼠; 1:500; 图 1f
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化-冰冻切片在大鼠样品上浓度为1:100 (图 5a) 和 被用于免疫印迹在大鼠样品上浓度为1:500 (图 1f). Brain Behav Immun (2017) ncbi
小鼠 单克隆(76B357.1)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1b
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图 1b). Arthritis Res Ther (2017) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; 小鼠; 1:1000; 图 2a
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 2a). Nat Commun (2017) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 大鼠; 图 6
艾博抗(上海)贸易有限公司Toll样受体4抗体(abcam, ab30667)被用于被用于免疫印迹在大鼠样品上 (图 6). BMC Cancer (2016) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 小鼠; 图 4
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于免疫印迹在小鼠样品上 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; 大鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫印迹在大鼠样品上浓度为1:1000 (图 4b). Mol Cell Endocrinol (2016) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 小鼠; 图 9a
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于免疫印迹在小鼠样品上 (图 9a). Oncotarget (2016) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 图 s11
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab171260)被用于被用于抑制或激活实验在人类样品上 (图 s11). Part Fibre Toxicol (2016) ncbi
小鼠 单克隆(HTA125)
  • 免疫组化; 大鼠; 1:200; 图 1b
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于免疫组化在大鼠样品上浓度为1:200 (图 1b). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 1
  • 免疫印迹; 小鼠; 图 1
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s5
  • 免疫印迹; 人类; 图 s2
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫组化-冰冻切片在小鼠样品上 (图 1), 被用于免疫印迹在小鼠样品上 (图 1), 被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图 s5) 和 被用于免疫印迹在人类样品上 (图 s2). PLoS ONE (2016) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; 小鼠; 图 2bb
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫印迹在小鼠样品上 (图 2bb). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫细胞化学在人类样品上 (图 2) 和 被用于免疫印迹在人类样品上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(76B357.1)
  • 免疫组化-石蜡切片; 大鼠; 图 6
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化-石蜡切片在大鼠样品上 (图 6). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556/ab30667)被用于被用于免疫印迹在大鼠样品上. Sci Rep (2015) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556/ab30667)被用于被用于免疫印迹在大鼠样品上. Sci Rep (2015) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 2
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于流式细胞仪在人类样品上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(HTA125)
  • 免疫细胞化学; 猕猴; 图 2a
  • 免疫印迹; 猕猴; 图 2b
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于免疫细胞化学在猕猴样品上 (图 2a) 和 被用于免疫印迹在猕猴样品上 (图 2b). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 2c
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 2c). Sci Rep (2015) ncbi
小鼠 单克隆(HTA125)
  • 免疫组化; 大鼠; 1:150; 图 3a
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab30667)被用于被用于免疫组化在大鼠样品上浓度为1:150 (图 3a). Sci Rep (2015) ncbi
小鼠 单克隆(HTA125)
  • 免疫组化; 大鼠; 1:100; 图 2d
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab8376)被用于被用于免疫组化在大鼠样品上浓度为1:100 (图 2d). Exp Ther Med (2015) ncbi
大鼠 单克隆(MTS510)
  • 免疫印迹; 小鼠; 1:500
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab-95562)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Neuroscience (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab-13867)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Neuroscience (2014) ncbi
小鼠 单克隆(76B357.1)
  • 免疫组化-石蜡切片; 大鼠; 1:100
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:100. Mol Pharm (2014) ncbi
小鼠 单克隆(76B357.1)
  • 免疫组化-石蜡切片; 人类; 1:200
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Mol Med Rep (2014) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; scFv; 图 3
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab22048)被用于被用于免疫印迹在scFv样品上 (图 3). Nat Commun (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200
  • 免疫印迹; 小鼠; 1:500
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 和 被用于免疫印迹在小鼠样品上浓度为1:500. Eur J Pain (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫组化-石蜡切片在大鼠样品上 和 被用于免疫印迹在大鼠样品上. World J Gastroenterol (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13867)被用于被用于免疫印迹在人类样品上. Autophagy (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫组化-石蜡切片在大鼠样品上. Cell Death Dis (2013) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:200
  • 免疫印迹; 大鼠; 1:500
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫组化在大鼠样品上浓度为1:200 和 被用于免疫印迹在大鼠样品上浓度为1:500. Pain (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 5h
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13556)被用于被用于免疫印迹在小鼠样品上 (图 5h). Nat Commun (2013) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 1
艾博抗(上海)贸易有限公司Toll样受体4抗体(Abcam, ab13867)被用于被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图 1). Endocrinology (2013) ncbi
赛默飞世尔
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 6). J Leukoc Biol (2017) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 1
  • 免疫组化; 人类; 图 2
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 1) 和 被用于免疫组化在人类样品上 (图 2). Eur J Immunol (2017) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 6b
赛默飞世尔Toll样受体4抗体(eBioscience, 12-9917)被用于被用于流式细胞仪在人类样品上 (图 6b). Retrovirology (2017) ncbi
小鼠 单克隆(76B357.1)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔Toll样受体4抗体(Thermo Scientific, 76B357.1)被用于被用于流式细胞仪在人类样品上 (图 1c). J Immunol (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 1e
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 1e). PLoS ONE (2016) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; 人类; 1:1000; 图 5b
赛默飞世尔Toll样受体4抗体(Thermo Fisher Scientific, MA5-16216)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5b). Mol Cells (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 2). J Leukoc Biol (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔Toll样受体4抗体(eBioscience, 53-9917-41)被用于被用于流式细胞仪在人类样品上 (图 5). Stem Cell Reports (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 4c
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 4c). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 图 4
  • 免疫印迹; 人类; 图 5
赛默飞世尔Toll样受体4抗体(Cell Signaling Technology, 48-2300)被用于被用于免疫细胞化学在人类样品上 (图 4) 和 被用于免疫印迹在人类样品上 (图 5). J Immunol (2014) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 1-20 ug/ml
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于抑制或激活实验在人类样品上浓度为1-20 ug/ml. J Immunol (2014) ncbi
小鼠 单克隆(HTA125)
  • 免疫细胞化学; 人类
赛默飞世尔Toll样受体4抗体(eBioscience, 12-9917)被用于被用于免疫细胞化学在人类样品上. Sci Signal (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:100
赛默飞世尔Toll样受体4抗体(ThermoFisher, PA5-23124)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. Int J Mol Sci (2014) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上. J Immunol (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠
赛默飞世尔Toll样受体4抗体(Invitrogen, 48-2300)被用于被用于免疫组化-石蜡切片在小鼠样品上. PLoS ONE (2014) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 8
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于流式细胞仪在人类样品上 (图 8). Retrovirology (2013) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 图 3
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于抑制或激活实验在人类样品上 (图 3). J Immunol (2010) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 小鼠; 10 ug/ml
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于抑制或激活实验在小鼠样品上浓度为10 ug/ml. J Neurosci (2009) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 人类; 图 4
赛默飞世尔Toll样受体4抗体(eBioscience, HTA125)被用于被用于免疫印迹在人类样品上 (图 4). J Virol (2008) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 8
赛默飞世尔Toll样受体4抗体(eBioscience, HTA-125)被用于被用于流式细胞仪在人类样品上 (图 8). Eur J Immunol (2007) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
赛默飞世尔Toll样受体4抗体(eBiosciences, HTA125)被用于被用于流式细胞仪在人类样品上. J Immunol (2005) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔Toll样受体4抗体(Zymed, HTA125)被用于被用于流式细胞仪在人类样品上 (图 1). J Leukoc Biol (2005) ncbi
BioLegend
小鼠 单克隆(HTA125)
  • 免疫印迹; 人类; 图 1a
BioLegendToll样受体4抗体(BioLegend, HTA125)被用于被用于免疫印迹在人类样品上 (图 1a). Thromb Res (2017) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 图 4a
BioLegendToll样受体4抗体(BioLegend, HTA125)被用于被用于流式细胞仪在人类样品上 (图 4a). Sci Rep (2016) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 图 2a
BioLegendToll样受体4抗体(BioLegend, HTA125)被用于被用于抑制或激活实验在人类样品上 (图 2a). Sci Rep (2016) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 图 3
BioLegendToll样受体4抗体(Biolegend, HTA 125)被用于被用于抑制或激活实验在人类样品上 (图 3). Thromb Haemost (2016) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 图 3a
BioLegendToll样受体4抗体(Biolegend, HTA125)被用于被用于抑制或激活实验在人类样品上 (图 3a). Eur J Immunol (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
BioLegendToll样受体4抗体(Biolegend, HTA125)被用于被用于流式细胞仪在人类样品上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 表 1
BioLegendToll样受体4抗体(Biolegend, HTA125)被用于被用于流式细胞仪在人类样品上 (表 1). Nat Immunol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(25)
  • 免疫印迹; 人类; 1:1000; 图 8b
圣克鲁斯生物技术Toll样受体4抗体(Santa Cruz, sc293072)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 8b). Br J Pharmacol (2018) ncbi
小鼠 单克隆(25)
  • 免疫沉淀; 大鼠; 1:100; 图 7
  • 免疫印迹; 大鼠; 1:50; 图 6
圣克鲁斯生物技术Toll样受体4抗体(Santa Cruz Biotechnology, sc-293072)被用于被用于免疫沉淀在大鼠样品上浓度为1:100 (图 7) 和 被用于免疫印迹在大鼠样品上浓度为1:50 (图 6). Int J Mol Med (2017) ncbi
小鼠 单克隆(HTA125)
  • 免疫印迹; 人类; 图 5d
圣克鲁斯生物技术Toll样受体4抗体(Santa Cruz, sc-13593)被用于被用于免疫印迹在人类样品上 (图 5d). Arterioscler Thromb Vasc Biol (2016) ncbi
大鼠 单克隆(MTS510)
  • 流式细胞仪; 小鼠
圣克鲁斯生物技术Toll样受体4抗体(Santa Cruz Biotechnology, sc-13591)被用于被用于流式细胞仪在小鼠样品上. Exp Mol Med (2014) ncbi
小鼠 单克隆(HTA125)
  • 抑制或激活实验; 人类; 100 ug/ml; 图 2
圣克鲁斯生物技术Toll样受体4抗体(Santa Cruz, sc-13593 L)被用于被用于抑制或激活实验在人类样品上浓度为100 ug/ml (图 2). Innate Immun (2014) ncbi
安迪生物R&D
小鼠 单克隆(610029)
  • 免疫印迹; 人类; 图 7f
安迪生物R&DToll样受体4抗体(R&D Systems, MAB14782)被用于被用于免疫印迹在人类样品上 (图 7f). J Virol (2017) ncbi
小鼠 单克隆(285227)
  • 免疫印迹; 人类; 图 6
安迪生物R&DToll样受体4抗体(R&D Systems, MAB1478)被用于被用于免疫印迹在人类样品上 (图 6). Biomed Res Int (2016) ncbi
小鼠 单克隆(610015)
  • 流式细胞仪; 人类; 图 st1
安迪生物R&DToll样受体4抗体(R&D Systems, FAB6248P)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
山羊 多克隆
  • 免疫组化; 大鼠; 图 4
  • 免疫组化; 人类; 图 1
安迪生物R&DToll样受体4抗体(R&D Systems, AF1478)被用于被用于免疫组化在大鼠样品上 (图 4) 和 被用于免疫组化在人类样品上 (图 1). Sci Rep (2015) ncbi
小鼠 单克隆(285227)
  • 免疫印迹; 人类
安迪生物R&DToll样受体4抗体(RnD, MAB-1478)被用于被用于免疫印迹在人类样品上. J Biomed Mater Res A (2015) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类
安迪生物R&DToll样受体4抗体(R&DSystems, AF1478)被用于被用于抑制或激活实验在人类样品上. J Biol Chem (2014) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类
安迪生物R&DToll样受体4抗体(R&D Systems, AF1478)被用于被用于抑制或激活实验在人类样品上. J Biol Chem (2013) ncbi
Novus Biologicals
小鼠 单克隆(76B357.1)
  • 免疫印迹; 小鼠; 图 s2
Novus BiologicalsToll样受体4抗体(Novus Biologicals, NB100-56566SS)被用于被用于免疫印迹在小鼠样品上 (图 s2). Sci Rep (2018) ncbi
小鼠 单克隆(76B357.1)
  • 流式细胞仪; 大鼠; 图 s1a
Novus BiologicalsToll样受体4抗体(Novus Biologicals, 76B357.1)被用于被用于流式细胞仪在大鼠样品上 (图 s1a). PLoS ONE (2016) ncbi
小鼠 单克隆(76B357.1)
  • 免疫印迹; 小鼠; 1:1000; 图 s11
Novus BiologicalsToll样受体4抗体(Novus, NB100-56566)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s11). Sci Rep (2016) ncbi
小鼠 单克隆(76B357.1)
  • 免疫细胞化学; 小鼠
  • 免疫组化; 小鼠; 1:500; 图 1a
  • 免疫印迹; 小鼠
Novus BiologicalsToll样受体4抗体(Imgenex, 76B357.1)被用于被用于免疫细胞化学在小鼠样品上, 被用于免疫组化在小鼠样品上浓度为1:500 (图 1a) 和 被用于免疫印迹在小鼠样品上. J Cell Mol Med (2014) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类; 表 1
伯乐(Bio-Rad)公司Toll样受体4抗体(AbD Serotec, MCA2061PE)被用于被用于流式细胞仪在人类样品上 (表 1). PLoS ONE (2016) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司Toll样受体4抗体(AbD Serotec, MCA2061PE)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2015) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司Toll样受体4抗体(AbD Serotec, HTA125)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2014) ncbi
小鼠 单克隆(HTA125)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司Toll样受体4抗体(AbdSerotec, HTA125)被用于被用于流式细胞仪在人类样品上. Inflamm Bowel Dis (2014) ncbi
亚诺法生技股份有限公司
小鼠 单克隆(3B6)
  • 免疫组化; 小鼠; 1:1000; 图 3d
  • 免疫印迹; 小鼠; 1:1000; 图 s1
  • 免疫组化; 人类; 1:1000; 图 2d
  • 免疫印迹; 人类; 1:1000; 图 s1
亚诺法生技股份有限公司Toll样受体4抗体(Abnova Corporation, H00007099-M02)被用于被用于免疫组化在小鼠样品上浓度为1:1000 (图 3d), 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s1), 被用于免疫组化在人类样品上浓度为1:1000 (图 2d) 和 被用于免疫印迹在人类样品上浓度为1:1000 (图 s1). J Histochem Cytochem (2016) ncbi
小鼠 单克隆(3B6)
  • 免疫印迹; 人类; 1:1000
亚诺法生技股份有限公司Toll样受体4抗体(Abnova, H00007099-M02)被用于被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2015) ncbi
武汉三鹰
兔 多克隆
  • 酶联免疫吸附测定; 人类; 图 1a
武汉三鹰Toll样受体4抗体(Proteintech Group, 19811-1-AP)被用于被用于酶联免疫吸附测定在人类样品上 (图 1a). J Cell Mol Med (2017) ncbi
LifeSpan Biosciences
小鼠 单克隆(1E11)
  • 免疫组化-石蜡切片; 人类
LifeSpan BiosciencesToll样受体4抗体(Lifespan Biosciences, LS-B2254)被用于被用于免疫组化-石蜡切片在人类样品上. J Dermatol (2015) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 流式细胞仪; 人类; 图 4b
赛信通(上海)生物试剂有限公司Toll样受体4抗体(Cell Signaling, 2209)被用于被用于流式细胞仪在人类样品上 (图 4b). Invest New Drugs (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司Toll样受体4抗体(Cell Signaling Technology, 2633S)被用于被用于免疫印迹在人类样品上. PLoS Pathog (2014) ncbi
文章列表
  1. Bhattacharjee P, Keyel P. Cholesterol-dependent cytolysins impair pro-inflammatory macrophage responses. Sci Rep. 2018;8:6458 pubmed 出版商
  2. Lu Y, Kim N, Jiang Y, Zhang H, Zheng D, Zhu F, et al. Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. Br J Pharmacol. 2018;175:1085-1099 pubmed 出版商
  3. Chen X, Tang L, Fu Y, Wang Y, Han Z, Meng J. Paralemmin-3 contributes to lipopolysaccharide-induced inflammatory response and is involved in lipopolysaccharide-Toll-like receptor-4 signaling in alveolar macrophages. Int J Mol Med. 2017;40:1921-1931 pubmed 出版商
  4. Hally K, La Flamme A, Larsen P, Harding S. Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction. Thromb Res. 2017;158:8-15 pubmed 出版商
  5. Shi Y, Zhang X, Chen C, Tang M, Wang Z, Liang X, et al. Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways. Brain Behav Immun. 2017;66:244-256 pubmed 出版商
  6. Bzowska M, Nogieć A, Bania K, Zygmunt M, Zarebski M, Dobrucki J, et al. Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages. J Leukoc Biol. 2017;102:763-774 pubmed 出版商
  7. Mitterreiter J, Ouwendijk W, van Velzen M, van Nierop G, Osterhaus A, Verjans G. Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors. Eur J Immunol. 2017;47:1181-1187 pubmed 出版商
  8. Peng J, Wu Y, Tian X, Pang J, Kuai L, Cao F, et al. High-Throughput Sequencing and Co-Expression Network Analysis of lncRNAs and mRNAs in Early Brain Injury Following Experimental Subarachnoid Haemorrhage. Sci Rep. 2017;7:46577 pubmed 出版商
  9. Rong H, Zhao Z, Feng J, Lei Y, Wu H, Sun R, et al. The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats. Brain Behav Immun. 2017;64:195-207 pubmed 出版商
  10. Alvarez Carbonell D, Garcia Mesa Y, Milne S, Das B, Dobrowolski C, Rojas R, et al. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells. Retrovirology. 2017;14:9 pubmed 出版商
  11. Dakin S, Buckley C, Al Mossawi M, Hedley R, Martinez F, Wheway K, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19:16 pubmed 出版商
  12. Luo L, Bokil N, Wall A, Kapetanovic R, Lansdaal N, Marceline F, et al. SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nat Commun. 2017;8:14133 pubmed 出版商
  13. Cianciola N, Chung S, Manor D, Carlin C. Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum. J Virol. 2017;91: pubmed 出版商
  14. Su J, Zhou H, Liu X, Nilsson J, Fredrikson G, Zhao M. oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow. J Cell Mol Med. 2017;21:929-940 pubmed 出版商
  15. Hadadi E, Zhang B, Baidžajevas K, Yusof N, Puan K, Ong S, et al. Differential IL-1? secretion by monocyte subsets is regulated by Hsp27 through modulating mRNA stability. Sci Rep. 2016;6:39035 pubmed 出版商
  16. Rigo Adrover M, Franch A, Castell M, Pérez Cano F. Preclinical Immunomodulation by the Probiotic Bifidobacterium breve M-16V in Early Life. PLoS ONE. 2016;11:e0166082 pubmed 出版商
  17. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  18. Sadeghi K, Wisgrill L, Wessely I, Diesner S, Schuller S, Dürr C, et al. GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes. PLoS ONE. 2016;11:e0162667 pubmed 出版商
  19. An L, Gorman J, Stephens G, Swerdlow B, Warrener P, Bonnell J, et al. Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways. Sci Rep. 2016;6:33346 pubmed 出版商
  20. Chen N, Xia X, Qin L, Luo L, Han S, Wang G, et al. Effects of 8-Week Hatha Yoga Training on Metabolic and Inflammatory Markers in Healthy, Female Chinese Subjects: A Randomized Clinical Trial. Biomed Res Int. 2016;2016:5387258 pubmed 出版商
  21. Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, et al. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. Sci Rep. 2016;6:31895 pubmed 出版商
  22. Shi D, Shi G, Xie J, Du X, Yang H. MicroRNA-27a Inhibits Cell Migration and Invasion of Fibroblast-Like Synoviocytes by Targeting Follistatin-Like Protein 1 in Rheumatoid Arthritis. Mol Cells. 2016;39:611-8 pubmed 出版商
  23. Aldabbous L, Abdul Salam V, McKinnon T, Duluc L, Pepke Zaba J, Southwood M, et al. Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension. Arterioscler Thromb Vasc Biol. 2016;36:2078-87 pubmed 出版商
  24. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed 出版商
  25. Huhta H, Helminen O, Kauppila J, Salo T, Porvari K, Saarnio J, et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J Histochem Cytochem. 2016;64:470-82 pubmed 出版商
  26. Pagano S, Carbone F, Burger F, Roth A, Bertolotto M, Pane B, et al. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis. Thromb Haemost. 2016;116:554-64 pubmed 出版商
  27. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  28. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  29. Wang X, Wan H, Wei X, Zhang Y, Qu P. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice. Mol Med Rep. 2016;14:49-56 pubmed 出版商
  30. Sominsky L, Ziko I, Soch A, Smith J, Spencer S. Neonatal overfeeding induces early decline of the ovarian reserve: Implications for the role of leptin. Mol Cell Endocrinol. 2016;431:24-35 pubmed 出版商
  31. Lindsay S, Johnstone S, McGrath M, Mallinson D, Barnett S. Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells. Stem Cell Reports. 2016;6:729-742 pubmed 出版商
  32. Fan H, Qi D, Yu C, Zhao F, Liu T, Zhang Z, et al. Paeonol protects endotoxin-induced acute kidney injury: potential mechanism of inhibiting TLR4-NF-?B signal pathway. Oncotarget. 2016;7:39497-39510 pubmed 出版商
  33. Hiraku Y, Guo F, Ma N, Yamada T, Wang S, Kawanishi S, et al. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation. Part Fibre Toxicol. 2016;13:16 pubmed 出版商
  34. Leng Y, Yi M, Fan J, Bai Y, Ge Q, Yao G. Effects of acute intra-abdominal hypertension on multiple intestinal barrier functions in rats. Sci Rep. 2016;6:22814 pubmed 出版商
  35. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  36. Zwolak A, SÅ‚abczyÅ„ska O, Semeniuk J, Daniluk J, Szuster Ciesielska A. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. PLoS ONE. 2016;11:e0150233 pubmed 出版商
  37. Steiner M, Hawranek T, Schneider M, Ferreira F, Horejs Hoeck J, Harrer A, et al. Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels. PLoS ONE. 2016;11:e0149275 pubmed 出版商
  38. Lai C, Wang K, Lee F, Tsai H, Ma C, Cheng T, et al. Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm. PLoS ONE. 2016;11:e0146565 pubmed 出版商
  39. Li G, Wu X, Yang L, He Y, Liu Y, Jin X, et al. TLR4-mediated NF-κB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis. Int J Mol Med. 2016;37:99-107 pubmed 出版商
  40. Zwolak A, Szuster Ciesielska A, Daniluk J, SÅ‚abczyÅ„ska O, Kandefer SzerszeÅ„ M. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLoS ONE. 2015;10:e0143851 pubmed 出版商
  41. Ulbrich F, Kaufmann K, Roesslein M, Wellner F, Auwärter V, Kempf J, et al. Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4. PLoS ONE. 2015;10:e0143887 pubmed 出版商
  42. Nozako M, Koyama T, Nagano C, Sato M, Matsumoto S, Mitani K, et al. An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats. PLoS ONE. 2015;10:e0143979 pubmed 出版商
  43. Shin W, Jeon M, Leem E, Won S, Jeong K, Park S, et al. Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson's disease. Sci Rep. 2015;5:14764 pubmed 出版商
  44. Hwang S, Cho H, Park S, Lee W, Lee H, Lee D, et al. Characteristics of Human Turbinate-Derived Mesenchymal Stem Cells Are Not Affected by Allergic Condition of Donor. PLoS ONE. 2015;10:e0138041 pubmed 出版商
  45. Feng Y, Guo H, Yuan F, Shen M. Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell. PLoS ONE. 2015;10:e0136175 pubmed 出版商
  46. Lin J, Du Y, Cai W, Kuang R, Chang T, Zhang Z, et al. Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats. Sci Rep. 2015;5:12549 pubmed 出版商
  47. Pohjanen V, Koivurova O, Huhta H, Helminen O, Mäkinen J, Karhukorpi J, et al. Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms +896 and +1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk. PLoS ONE. 2015;10:e0131553 pubmed 出版商
  48. Elewa R, Abdallah M, Zouboulis C. Age-associated skin changes in innate immunity markers reflect a complex interaction between aging mechanisms in the sebaceous gland. J Dermatol. 2015;42:467-76 pubmed 出版商
  49. Wang L, Liu X, Chen H, Chen Z, Weng X, Qiu T, et al. Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-κB pathway. Exp Ther Med. 2015;9:1253-1258 pubmed
  50. Guzmán E, Maers K, Roberts J, Kemami Wangun H, Harmody D, Wright A. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Invest New Drugs. 2015;33:86-94 pubmed 出版商
  51. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  52. Oda M, Yamamoto H, Shibutani M, Nakano M, Yabiku K, Tarui T, et al. Vizantin inhibits endotoxin-mediated immune responses via the TLR 4/MD-2 complex. J Immunol. 2014;193:4507-14 pubmed 出版商
  53. Landy J, Al Hassi H, Ronde E, English N, Mann E, Bernardo D, et al. Innate immune factors in the development and maintenance of pouchitis. Inflamm Bowel Dis. 2014;20:1942-9 pubmed 出版商
  54. Kunda P, Cavicchia J, Acosta C. Lipopolysaccharides and trophic factors regulate the LPS receptor complex in nodose and trigeminal neurons. Neuroscience. 2014;280:60-72 pubmed 出版商
  55. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  56. Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014;11:3503-14 pubmed 出版商
  57. Weng H, Liu H, Deng Y, Xie Y, Shen G. Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus. Mol Med Rep. 2014;10:1765-71 pubmed 出版商
  58. Kyriakidis N, Kapsogeorgou E, Gourzi V, Konsta O, Baltatzis G, Tzioufas A. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin Exp Immunol. 2014;178:548-60 pubmed 出版商
  59. Liaunardy Jopeace A, Bryant C, Gay N. The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane. Sci Signal. 2014;7:ra70 pubmed 出版商
  60. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed 出版商
  61. Ye Y, Xu H, Zhang X, Li Z, Jia Y, He X, et al. Association between toll-like receptor 4 expression and neural stem cell proliferation in the hippocampus following traumatic brain injury in mice. Int J Mol Sci. 2014;15:12651-64 pubmed 出版商
  62. Luo L, Wall A, Yeo J, Condon N, Norwood S, Schoenwaelder S, et al. Rab8a interacts directly with PI3K? to modulate TLR4-driven PI3K and mTOR signalling. Nat Commun. 2014;5:4407 pubmed 出版商
  63. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed 出版商
  64. Chen Z, Zhang X, Yu L, Hua R, Zhao X, Qin X, et al. Spinal toll-like receptor 4-mediated signalling pathway contributes to visceral hypersensitivity induced by neonatal colonic irritation in rats. Eur J Pain. 2015;19:176-86 pubmed 出版商
  65. Ma J, Chadban S, Zhao C, Chen X, Kwan T, Panchapakesan U, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS ONE. 2014;9:e97985 pubmed 出版商
  66. Chattergoon M, Latanich R, Quinn J, Winter M, Buckheit R, Blankson J, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 2014;10:e1004082 pubmed 出版商
  67. Schuster A, Klotz M, Schwab T, Di Liddo R, Bertalot T, Schrenk S, et al. Maintenance of the enteric stem cell niche by bacterial lipopolysaccharides? Evidence and perspectives. J Cell Mol Med. 2014;18:1429-43 pubmed 出版商
  68. Mogami H, Keller P, Shi H, Word R. Effect of thrombin on human amnion mesenchymal cells, mouse fetal membranes, and preterm birth. J Biol Chem. 2014;289:13295-307 pubmed 出版商
  69. Qian H, Shi J, Fan T, Lv J, Chen S, Song C, et al. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats. World J Gastroenterol. 2014;20:1822-32 pubmed 出版商
  70. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  71. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed 出版商
  72. Babu R, Brown A. A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology. 2013;10:155 pubmed 出版商
  73. Zhan Z, Xie X, Cao H, Zhou X, Zhang X, Fan H, et al. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy. 2014;10:257-68 pubmed 出版商
  74. Gu H, Werner J, Bergmann F, Whitcomb D, Buchler M, Fortunato F. Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis. 2013;4:e816 pubmed 出版商
  75. Wang L, Yang H, Sun Y, Yu F, Wu X. Signaling mechanism for Aspergillus fumigatus tolerance in corneal fibroblasts induced by LPS pretreatment. Innate Immun. 2014;20:563-73 pubmed 出版商
  76. Liu S, Liu Y, Song W, Song X. EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord. Pain. 2013;154:2823-35 pubmed 出版商
  77. Hiratsuka S, Ishibashi S, Tomita T, Watanabe A, Akashi Takamura S, Murakami M, et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun. 2013;4:1853 pubmed 出版商
  78. Mogami H, Kishore A, Shi H, Keller P, Akgul Y, Word R. Fetal fibronectin signaling induces matrix metalloproteases and cyclooxygenase-2 (COX-2) in amnion cells and preterm birth in mice. J Biol Chem. 2013;288:1953-66 pubmed 出版商
  79. Lukewich M, Lomax A. Toll-like receptor 4 activation reduces adrenal chromaffin cell excitability through a nuclear factor-?B-dependent pathway. Endocrinology. 2013;154:351-62 pubmed 出版商
  80. Ahmad U, Ali R, Lebastchi A, Qin L, Lo S, Yakimov A, et al. IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. J Immunol. 2010;185:1283-94 pubmed 出版商
  81. Reed Geaghan E, Savage J, Hise A, Landreth G. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci. 2009;29:11982-92 pubmed 出版商
  82. Nicol M, Mathys J, Pereira A, Ollington K, Ieong M, Skolnik P. Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells. J Virol. 2008;82:7790-8 pubmed 出版商
  83. Laudanski K, De A, Miller Graziano C. Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur J Immunol. 2007;37:2812-24 pubmed
  84. Sendide K, Reiner N, Lee J, Bourgoin S, Talal A, Hmama Z. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol. 2005;174:4210-9 pubmed
  85. Tunheim G, Schjetne K, Fredriksen A, Sandlie I, Bogen B. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes. J Leukoc Biol. 2005;77:303-10 pubmed